title: Comment on 'Difference between R5020 and the anti progestin RU486 in antiproliferative effects on human breast cancer cells'.
authors.forename: M R
authors.initials: MR
authors.lastname: Moore
mesh_terms: D001943:Breast Neoplasms / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects; D004963:Estrenes / Q000494:pharmacology*; D006801:Humans; D015735:Mifepristone; D009649:Norpregnadienes / Q000494:pharmacology*; D011397:Promegestone / Q000494:pharmacology*
chemical_list: D004963:Estrenes; D009649:Norpregnadienes; D015735:Mifepristone; D011397:Promegestone